Multi-Organ Sarcoidosis Treatment with Fumaric Acid Esters: A Case Report and Review of the Literature

被引:4
作者
Zouboulis, Christos C. [1 ]
Lippert, Undine
Karagiannidis, Ioannis
机构
[1] Dessau Med Ctr, Dept Dermatol, Dept Venereol, Dept Allergol, DE-06847 Dessau, Germany
关键词
Sarcoidosis; Treatment; Fumaric acid esters; Side effects; Review; SKIN DISEASES; THERAPY;
D O I
10.1159/000358428
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Sarcoidosis is a rare, systemic disease that is characterized by the formation of granulomas in various organs, including the skin. As the etiology remains unknown, the treatment of sarcoidosis is challenging. We present a 47-year-old female patient with progressive, multi-organ sarcoidosis who had a complete clinical improvement of the skin lesions, a moderate reduction in pulmonary opacities on chest X-ray, a marked subjective improvement in general status and pulmonary efficiency and a marked reduction in serum angiotensin-converting enzyme and soluble interleukin-2 receptor after 6 months of therapy with fumaric acid esters. The present case and similar reports in the literature highlight the probable efficacy of fumaric acid esters in the treatment of sarcoidosis and other non-infectious, granulomatous diseases. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:202 / 206
页数:5
相关论文
共 16 条
[1]  
[Anonymous], LANCET
[2]   Therapy of noninfectious granulomatous skin diseases with fumaric acid esters [J].
Breuer, K ;
Gutzmer, R ;
Völker, B ;
Kapp, A ;
Werfel, T .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (06) :1290-1295
[3]   Granuloma formation in pulmonary sarcoidosis [J].
Broos, Caroline E. ;
van Nimwegen, Menno ;
Hoogsteden, Henk C. ;
Hendriks, Rudi W. ;
Kool, Mirjam ;
van den Blink, Bernt .
FRONTIERS IN IMMUNOLOGY, 2013, 4
[4]  
Dummler U, 1998, ALLERGOLOGIE, V8, P387
[5]   Successful treatment of sarcoidosis with cutaneous and pulmonary involvement with fumaric acid ester [J].
Gutzmer, R ;
Kapp, A ;
Werfel, T .
HAUTARZT, 2004, 55 (06) :553-557
[6]  
Hoyer P, 2013, EXP DERMATOL, V22, pE36
[7]   Off-label use of fumarate therapy for granulomatous and inflammatory skin diseases other than psoriasis vulgaris: a retrospective study [J].
Klein, A. ;
Coras, B. ;
Landthaler, M. ;
Babilas, P. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (11) :1400-1406
[8]   Dimethyl fumarate - only an anti-psoriatic medication? [J].
Meissner, Markus ;
Valesky, Eva Maria ;
Kippenberger, Stefan ;
Kaufmann, Roland .
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (11) :793-802
[9]  
Moller DR, 1996, J IMMUNOL, V156, P4952
[10]   New Insights into Tumaric Acid Esters (Fumaderm®): Results of the second Expert Workshops [J].
Mrowietz, Ulrich ;
Altmeyer, Peter ;
Augustin, Matthias ;
Boehncke, Wolf-Henning ;
Bonnekoh, Bernd ;
Frambach, Yvonne ;
Gambichler, Thilo ;
Ghoreschi, Kamran ;
Hertl, Michael ;
Hund, Anna-Carina ;
Jacobi, Arnd ;
Kuhn, Annegret ;
Ludwig, Ralf J. ;
Luger, Thomas ;
Martin, Stefan F. ;
Merk, Hans ;
Norgauer, Johannes ;
Reich, Kristian ;
Rostami-Yazdi, Martin ;
Sabat, Robert ;
Schaekel, Knut ;
Scharffetter-Kochanek, Karin ;
Schoen, Michael Peter ;
Scola, Nina ;
Sticherling, Michael ;
Thaci, Diamant ;
Wilsmann-Theis, Dagmar ;
Viehweg, Antje ;
Wozel, Gottfried ;
Zouboulis, Christos C. ;
Neureither, Marcus .
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 :1-15